Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemia von Dorrance, A M, Neviani, P, Ferenchak, G J, Huang, X, Nicolet, D, Maharry, K S, Ozer, H G, Hoellarbauer, P, Khalife, J, Hill, E B, Yadav, M, Bolon, B N, Lee, R J, Lee, L J, Croce, C M, Garzon, R, Caligiuri, M A, Bloomfield, C D, Marcucci, G

Volltext

Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia von Niederwieser, C, Kohlschmidt, J, Volinia, S, Whitman, S P, Metzeler, K H, Eisfeld, A-K, Maharry, K, Yan, P, Frankhouser, D, Becker, H, Schwind, S, Carroll, A J, Nicolet, D, Mendler, J H, Curfman, J P, Wu, Y-Z, Baer, M R, Powell, B L, Kolitz, J E, Moore, J O, Carter, T H, Bundschuh, R, Larson, R A, Stone, R M, Mrózek, K, Marcucci, G, Bloomfield, C D

Volltext

GAS6 expression identifies high-risk adult AML patients: potential implications for therapy von Whitman, S P, Kohlschmidt, J, Maharry, K, Volinia, S, Mrózek, K, Nicolet, D, Schwind, S, Becker, H, Metzeler, K H, Mendler, J H, Eisfeld, A-K, Carroll, A J, Powell, B L, Carter, T H, Baer, M R, Kolitz, J E, Park, I-K, Stone, R M, Caligiuri, M A, Marcucci, G, Bloomfield, C D

Volltext

BEACON CRC: a randomized, 3-Arm, phase 3 study of encorafenib and cetuximab with or without binimetinib vs. choice of either irinotecan or FOLFIRI plus cetuximab in BRAF V600E–muta... von Kopetz, S., Grothey, A., Van Cutsem, E., Yaeger, R., Wasan, H., Yoshino, T., Desai, J., Ciardiello, F., Gollerkeri, A., Maharry, K., Loupakis, F., Hong, Y., Steeghs, N., Guren, T., Arkenau, H., García Alfonso, P., Sandor, V., Christy-Bittel, J., Anderson, L., Tabernero, J.

Volltext

BEACON CRC study safety lead-in: Assessment of the BRAF inhibitor encorafenib + MEK inhibitor binimetinib + anti–epidermal growth factor receptor antibody cetuximab for BRAFV600E m... von Van Cutsem, E., Cuyle, P., Huijberts, S., Schellens, J., Elez, E., Yaeger, R., Fakih, M., Montagut, C., Peeters, M., Desai, J., Yoshino, T., Ciardiello, F., Wasan, H., Maharry, K., Christy-Bittel, J., Gollerkeri, A., Kopetz, S., Grothey, A., Tabernero, J.

Volltext

Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: insights from the BEACON CRC study von Tabernero, J., Velez, L., Trevino, T.L., Grothey, A., Yaeger, R., Van Cutsem, E., Wasan, H., Desai, J., Ciardiello, F., Yoshino, T., Gollerkeri, A., Maharry, K., Christy-Bittel, J., Kopetz, S.

Volltext

A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid... von Metzeler, K H, Maharry, K, Kohlschmidt, J, Volinia, S, Mrózek, K, Becker, H, Nicolet, D, Whitman, S P, Mendler, J H, Schwind, S, Eisfeld, A-K, Wu, Y-Z, Powell, B L, Carter, T H, Wetzler, M, Kolitz, J E, Baer, M R, Carroll, A J, Stone, R M, Caligiuri, M A, Marcucci, G, Bloomfield, C D

Volltext

Prognostic gene mutations and distinct gene- and microRNA-expression signatures in acute myeloid leukemia with a sole trisomy 8 von Becker, H, Maharry, K, Mrózek, K, Volinia, S, Eisfeld, A-K, Radmacher, M D, Kohlschmidt, J, Metzeler, K H, Schwind, S, Whitman, S P, Mendler, J H, Wu, Y-Z, Nicolet, D, Paschka, P, Powell, B L, Carter, T H, Wetzler, M, Kolitz, J E, Carroll, A J, Baer, M R, Caligiuri, M A, Stone, R M, Marcucci, G, Bloomfield, C D

Volltext

The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemia von Whitman, S P, Caligiuri, M A, Maharry, K, Radmacher, M D, Kohlschmidt, J, Becker, H, Mrózek, K, Wu, Y-Z, Schwind, S, Metzeler, K H, Mendler, J H, Wen, J, Baer, M R, Powell, B L, Carter, T H, Kolitz, J E, Wetzler, M, Carroll, A J, Larson, R A, Marcucci, G, Bloomfield, C D

Volltext

Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acu... von BECKER, Heiko, MAHARRY, Kati, CARTER, Thomas H, KOLITZ, Jonathan E, WETZLER, Meir, CARROLL, Andrew J, BAER, Maria R, MOORE, Joseph O, CALIGIURI, Michael A, LARSON, Richard A, MARCUCCI, Guido, BLOOMFIELD, Clara D, RADMACHER, Michael D, MROZEK, Krzysztof, METZELER, Klaus H, WHITMAN, Susan P, SCHWIND, Sebastian, KOHLSCHMIDT, Jessica, WU, Yue-Zhong, POWELL, Bayard L

Volltext

Effects of a beverage containing an enzymatically induced-viscosity dietary fiber, with or without fructose, on the postprandial glycemic response to a high glycemic index food in... von WOLF, B. W, WOLEVER, T. M. S, LAI, C. S, BOLOGNESI, C, RADMARD, R, MAHARRY, K. S, GARLEB, K. A, HERTZLER, S. R, FIRKINS, J. L

Volltext

SO-21 Management of adverse events associated with encorafenib plus cetuximab in patients with BRAF V600E-mutant metastatic colorectal cancer (The BEACON CRC Study) von Velez, L., Trevino, T., Kopetz, S., Grothey, A., Yaeger, R., Gollerkeri, A., Maharry, K., Tabernero, J.

Volltext

LBA-7 Encorafenib plus cetuximab with or without binimetinib for BRAFV600E metastatic colorectal cancer (mCRC): Relationship between carcinoembryonic antigen (CEA) and clinical out... von Grothey, A., Kopetz, S., Yaeger, R., Van Cutsem, E., Wasan, H., Desai, J., Ciardiello, F., Yoshino, T., Maharry, K., Christy-Bittel, J., Gollerkeri, A., Tabernero, J.

Volltext

Prognostic Factors and Outcome of Core Binding Factor Acute Myeloid Leukemia Patients With t(8;21) Differ From Those of Patients With inv(16): A Cancer and Leukemia Group B Study von MARCUCCI, Guido, MROZEK, Krzysztof, STERLING, Lisa J, VARDIMAN, James W, SCHIFFER, Charles A, CARROLL, Andrew J, LARSON, Richard A, BLOOMFIELD, Clara D, RUPPERT, Amy S, MAHARRY, Kati, KOLITZ, Jonathan E, MOORE, Joseph O, MAYER, Robert J, PETTENATI, Mark J, POWELL, Bayard L, EDWARDS, Colin G

Volltext

85MO Management of adverse events associated with encorafenib plus cetuximab in patients with BRAF V600E mutant metastatic colorectal cancer (BEACON CRC Study) von Chiu, C-F., Yeh, Y-M., Yeh, K-H., Desai, J., Price, T.J., Tebbutt, N., Tabernero, J., Velez, L., Trevino, T.L., Grothey, A., Yaeger, R., Gollerkeri, A., Maharry, K., Kopetz, S.

Volltext

A Computerized Reminder System to Increase the Use of Preventive Care for Hospitalized Patients von Dexter, Paul R, Perkins, Susan, Overhage, J. Marc, Maharry, Kati, Kohler, Richard B, McDonald, Clement J

Volltext

LBA32Encorafenib plus cetuximab with or without binimetinib for BRAF V600E–mutant metastatic colorectal cancer: Expanded results from a randomized, 3-arm, phase III study vs the ch... von Tabernero, J, Grothey, A, Van Cutsem, E, Yaeger, R, Wasan, H, Yoshino, T, Desai, J, Ciardiello, F, Loupakis, F, Hong, Y Sang, Steeghs, N, Guren, T K, Arkenau, H-T, García-Alfonso, P, Gollerkeri, A, Pickard, M, Maharry, K, Christy-Bittel, J L, Anderson, L, Kopetz, S

Volltext

Encorafenib plus cetuximab with or without binimetinib for BRAF V600E–mutant metastatic colorectal cancer: Expanded results from a randomized, 3-arm, phase III study vs the choice... von Tabernero, J., Grothey, A., Van Cutsem, E., Yaeger, R., Wasan, H., Yoshino, T., Desai, J., Ciardiello, F., Loupakis, F., Hong, Y Sang, Steeghs, N., Guren, T.K., Arkenau, H.-T., García-Alfonso, P., Gollerkeri, A., Pickard, M., Maharry, K., Christy-Bittel, J.L., Anderson, L., Kopetz, S.

Volltext

LBA32 - Encorafenib plus cetuximab with or without binimetinib for BRAF V600E–mutant metastatic colorectal cancer: Expanded results from a randomized, 3-arm, phase III study vs the... von Tabernero, J., Grothey, A., Van Cutsem, E., Yaeger, R., Wasan, H., Yoshino, T., Desai, J., Ciardiello, F., Loupakis, F., Hong, Y Sang, Steeghs, N., Guren, T.K., Arkenau, H.-T., García-Alfonso, P., Gollerkeri, A., Pickard, M., Maharry, K., Christy-Bittel, J.L., Anderson, L., Kopetz, S.

Volltext

O-027BEACON CRC study safety lead-in: Assessment of the BRAF inhibitor encorafenib + MEK inhibitor binimetinib + anti-epidermal growth factor receptor antibody cetuximab for BRAFV6... von Van Cutsem, E, Cuyle, P, Huijberts, S, Schellens, J, Elez, E, Yaeger, R, Fakih, M, Montagut, C, Peeters, M, Desai, J, Yoshino, T, Ciardiello, F, Wasan, H, Maharry, K, Christy-Bittel, J, Gollerkeri, A, Kopetz, S, Grothey, A, Tabernero, J

Volltext